Ultima Viagra USA Ultima Pharmaceuticals

£96.00

Ultima Viagra from Ultima Pharmaceuticals contains sildenafil citrate for cardiovascular research applications. Research-grade compound supplied for in-vitro laboratory investigations only.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Ultima Viagra USA Ultima Pharmaceuticals
Ultima Viagra USA Ultima Pharmaceuticals
£96.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Sildenafil Citrate Research Overview

Ultima Viagra is a sildenafil citrate formulation manufactured by Ultima Pharmaceuticals for laboratory research applications. Sildenafil citrate is a phosphodiesterase type 5 (PDE5) inhibitor extensively studied in cardiovascular and vascular research. This compound selectively inhibits PDE5 enzyme activity, leading to increased cyclic guanosine monophosphate (cGMP) levels in smooth muscle cells. Research into sildenafil citrate has contributed significantly to understanding nitric oxide signalling pathways and their role in vascular physiology.

Originally developed for pulmonary arterial hypertension research, sildenafil citrate has become a valuable tool for investigating endothelial function, vascular remodelling, and smooth muscle relaxation mechanisms. The compound’s ability to modulate cGMP-dependent signalling makes it particularly useful for studying cardiovascular disease models and exploring therapeutic targets for vascular disorders. Researchers at Stroid UK Shop can access this pharmaceutical-grade compound for advancing their investigations into circulatory system function.

Laboratory Research Applications

In laboratory settings, sildenafil citrate serves multiple research purposes across cardiovascular, pulmonary, and cellular biology studies. Scientists investigate its effects on endothelial nitric oxide synthase (eNOS) activity, examining how PDE5 inhibition influences vascular tone regulation. Cell culture studies utilise sildenafil to evaluate smooth muscle cell proliferation, migration patterns, and apoptosis mechanisms. Tissue studies focus on arterial compliance, blood flow dynamics, and pressure-volume relationships in various vascular beds.

Comparative research often examines sildenafil alongside compounds from our sildenafil citrate research collection to evaluate relative potency and selectivity profiles. Advanced studies investigate the compound’s interactions with other signalling pathways, including adenosine monophosphate kinase (AMPK) activation and calcium channel modulation. Researchers also explore potential applications in selective androgen receptor modulator studies and peptide research where vascular function intersects with metabolic and hormonal pathways.

Technical Specifications

Ultima Viagra Research Compound Specifications
Parameter Specification
Active Ingredient Sildenafil Citrate
CAS Number 171599-83-0
Molecular Formula C₂₂H₃₀N₆O₄S·C₆H₈O₇
Molecular Weight 666.70 g/mol
Manufacturer Ultima Pharmaceuticals
Storage Conditions Room temperature, dry environment
Stability Stable under recommended storage conditions
Research Grade Laboratory standard

Research Compliance Statement

Ultima Viagra is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any clinical applications. This compound is provided to qualified research institutions and licensed laboratories for scientific investigation only. Researchers must ensure proper handling procedures, appropriate safety protocols, and compliance with relevant institutional guidelines. All studies should be conducted within controlled laboratory environments by trained personnel. This product has not been evaluated for safety, efficacy, or quality for human use and must not be used for any purpose other than legitimate scientific research.

Related